{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:51:09Z","timestamp":1775901069073,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T00:00:00Z","timestamp":1456876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.cmi.2015.12.023","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T05:48:47Z","timestamp":1472622527000},"page":"S136-S139","source":"Crossref","is-referenced-by-count":18,"special_numbering":"S5","title":["Vaccines against norovirus: state of the art trials in children and adults"],"prefix":"10.1016","volume":"22","author":[{"given":"F.","family":"Baehner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Bogaerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2015.12.023_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/gut.2011.238386","article-title":"Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice","volume":"61","author":"Tam","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.cmi.2015.12.023_bib2","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMsa1206589","article-title":"Norovirus and medically attended gastroenteritis in US children","volume":"368","author":"Payne","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2015.12.023_bib3","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1086\/657133","article-title":"High level of gastrointestinal nosocomial infections in the German surveillance system, 2002\u20132008","volume":"31","author":"Spackova","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"SS12","key":"10.1016\/j.cmi.2015.12.023_bib4","first-page":"1","article-title":"Outbreaks of acute gastroenteritis transmitted by person-to-person contact, environmental contamination, and unknown modes of transmission\u2014United States, 2009\u20132013. Surveillance summaries","volume":"64","author":"Wikswo","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2015.12.023_bib5","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/infdis\/jis251","article-title":"Noroviruses: the perfect human pathogens?","volume":"205","author":"Hall","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.023_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2005.01299.x","article-title":"Risk groups for clinical complications of norovirus infections: an outbreak investigation","volume":"12","author":"Mattner","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2015.12.023_bib7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ajic.2012.08.002","article-title":"Clinical characteristics of norovirus-associated deaths: a systematic literature review","volume":"41","author":"Trivedi","year":"2013","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.cmi.2015.12.023_bib8","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.1016\/j.vaccine.2012.09.040","article-title":"The potential economic value of a human norovirus vaccine for the United States","volume":"30","author":"Bartsch","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2015.12.023_bib9","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.4315\/0362-028X.JFP-11-417","article-title":"Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens","volume":"7","author":"Hoffman","year":"2012","journal-title":"J\u00a0Food Protect"},{"key":"10.1016\/j.cmi.2015.12.023_bib10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/infdis\/119.6.668","article-title":"Winter vomiting disease","volume":"119","author":"Adler","year":"1969","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.023_bib11","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1128\/JVI.10.5.1075-1081.1972","article-title":"Visualization by immune electron microscopy of a 27 nm particle associated with acute infectious nonbacterial gastroenteritis","volume":"10","author":"Kapikian","year":"1972","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2015.12.023_bib12","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1126\/science.2177224","article-title":"Norwalk virus genome cloning and characterization","volume":"14","author":"Xi","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.cmi.2015.12.023_bib13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jcv.2014.08.002","article-title":"Detection of human norovirus GIV.1 in China: a case report","volume":"61","author":"Ao","year":"2014","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cmi.2015.12.023_bib14","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3201\/eid1908.130472","article-title":"Duration of immunity to norovirus gastroenteritis","volume":"19","author":"Simmons","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.023_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jcv.2012.11.011","article-title":"Molecular epidemiology of noroviruses associated with acute sporadic gastroenteritis in children: global distribution of genogroups, genotypes and GII.4 variants","volume":"56","author":"Hoa Tran","year":"2013","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cmi.2015.12.023_bib16","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/1469-0691.12746","article-title":"Evolution of norovirus","volume":"20","author":"White","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2015.12.023_bib17","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3201\/eid2107.150226","article-title":"Gastroenteritis outbreaks caused by norovirus GII.17, Guangdong Province, China, 2014\u20132015","volume":"21","author":"Lu","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.023_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.tim.2005.04.004","article-title":"Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle","volume":"13","author":"Tan","year":"2005","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.cmi.2015.12.023_bib19","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/CVI.00196-15","article-title":"Serological correlates of protection against a GII.4 norovirus","volume":"22","author":"Atmar","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cmi.2015.12.023_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1126\/science.286.5438.287","article-title":"X-ray crystallographic structure of the Norwalk virus capsid","volume":"286","author":"Prasad","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.cmi.2015.12.023_bib21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/nnm.12.62","article-title":"Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus","volume":"7","author":"Tan","year":"2012","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.cmi.2015.12.023_bib22","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1128\/JVI.66.11.6527-6532.1992","article-title":"Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein","volume":"66","author":"Jiang","year":"1992","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2015.12.023_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0016-5085(99)70548-2","article-title":"Recombinant Norwalk virus\u2013like particles given orally to volunteers: phase I study","volume":"117","author":"Ball","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmi.2015.12.023_bib24","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1016\/j.vaccine.2006.03.080","article-title":"Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains","volume":"24","author":"LoBue","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2015.12.023_bib25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.clim.2012.05.006","article-title":"Intranasal vaccination with an adjuvanted Norwalk virus\u2013like particle vaccine elicits antigen-specific B memory responses in human adult volunteers","volume":"144","author":"Ramirez","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.cmi.2015.12.023_bib26","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1016\/j.vaccine.2011.05.027","article-title":"Intranasal delivery of Norwalk virus\u2013like particles formulated in an in situ gelling, dry powder vaccine","volume":"29","author":"Velasquez","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2015.12.023_bib27","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1128\/CVI.00230-10","article-title":"An intranasally delivered Toll-like receptor 7 agonist elicits robust systemic and mucosal responses to Norwalk virus\u2013like particles","volume":"17","author":"Velasquez","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cmi.2015.12.023_bib28","doi-asserted-by":"crossref","first-page":"e70409","DOI":"10.1371\/journal.pone.0070409","article-title":"Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice","volume":"8","author":"Tamminen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2015.12.023_bib29","doi-asserted-by":"crossref","first-page":"e63269","DOI":"10.1371\/journal.pone.0063269","article-title":"Norovirus P particle efficiently elicits innate, humoral and cellular immunity","volume":"8","author":"Fang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2015.12.023_bib30","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1016\/j.vaccine.2012.03.050","article-title":"Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations","volume":"30","author":"Parra","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2015.12.023_bib31","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1101245","article-title":"Norovirus vaccine against experimental human Norwalk virus illness","volume":"365","author":"Atmar","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2015.12.023_bib32","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/infdis\/jiu337","article-title":"A\u00a0novel intramuscular bivalent norovirus virus\u2013like particle vaccine candidate\u2014reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults","volume":"210","author":"Treanor","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.023_bib33","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/infdis\/jiu497","article-title":"Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults","volume":"211","author":"Bernstein","year":"2015","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2015.12.023_bib34","doi-asserted-by":"crossref","first-page":"e1001807","DOI":"10.1371\/journal.pmed.1001807","article-title":"Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial","volume":"12","author":"Lindesmith","year":"2015","journal-title":"PLoS Med"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1600015X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1600015X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:24:07Z","timestamp":1601054647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X1600015X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":34,"alternative-id":["S1198743X1600015X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2015.12.023","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}